drugset
drugset / Trial / NCT00000238

Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20

NCT00000238 ↗

Phase 2 Completed National Institute on Drug Abuse (NIDA) University of Vermont · collab
Treatment

Summary

The purpose of this study is to assess the degree in which opioid-dependent outpatients discount the value of an additional maintenance dose of buprenorphine under differing states of opioid deprivation.

Timeline

Start
1997-08
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Buprenorphine Other / unclassified — —

Indications

opiate dependence